Danaher’s new acquisition is the latest sign the health-care firm is staging a quiet recovery

3 mins read
75 views

Struggling life-sciences firm Danaher (DHR) has been one of the best-performing Club stocks in recent weeks, boosted by signs of a recovery at its bioprocessing business. And with the company set to close a key acquisition this week, Danaher’s stock is set up for a stronger 2024.

Read the full article here

Leave a Reply

Your email address will not be published.

Previous Story

Tucker Carlson’s former top producer at Fox News accused of sexual assault

Next Story

Elon Musk’s AI startup — X.AI — files to raise $1 billion in fresh capital

Latest from News